Teza Capital Management LLC Lowers Holdings in Teladoc Health, Inc. $TDOC

Key Points

• Teza Capital Management LLC significantly reduced its stake in Teladoc Health, selling 43,316 shares and trimming its position by 77.2% in the first quarter, now holding only 12,825 shares valued at approximately $102,000.
• Several institutional investors have increased their holdings in Teladoc Health, with Point72 Asset Management L.P. boosting their position by 33.6%, acquiring over 2.8 million additional shares.
• Analysts are mixed on Teladoc Health's stock, with an average rating of "Hold" and price targets ranging from $7.00 to $10.00, as the company faces challenges reflected in its recent earnings report.

Teza Capital Management LLC reduced its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 77.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,825 shares of the health services provider's stock after selling 43,316 shares during the period. Teza Capital Management LLC's holdings in Teladoc Health were worth $102,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of TDOC. Northern Trust Corp increased its stake in Teladoc Health by 10.7% in the 4th quarter. Northern Trust Corp now owns 1,679,382 shares of the health services provider's stock worth $15,266,000 after purchasing an additional 161,875 shares during the period. Mercer Global Advisors Inc. ADV increased its stake in Teladoc Health by 9.6% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider's stock worth $113,000 after purchasing an additional 1,089 shares during the period. Algert Global LLC purchased a new position in Teladoc Health in the 4th quarter worth approximately $313,000. Graham Capital Management L.P. purchased a new position in Teladoc Health in the 4th quarter worth approximately $183,000. Finally, Moore Capital Management LP purchased a new position in Teladoc Health in the 4th quarter worth approximately $1,622,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Mizuho began coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price target on the stock. Evercore ISI lifted their price objective on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Bank of America cut their price objective on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 28th. Finally, Truist Financial cut their price objective on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Tuesday, May 27th. Six analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $9.80.

Teladoc Health Stock Down 0.9%

Shares of NYSE TDOC traded down $0.07 during mid-day trading on Friday, hitting $7.70. 3,034,250 shares of the stock traded hands, compared to its average volume of 4,355,109. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21. The company has a market cap of $1.36 billion, a price-to-earnings ratio of -6.47 and a beta of 1.84. The stock has a fifty day moving average price of $7.71 and a 200-day moving average price of $7.71.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The company had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. During the same period in the previous year, the company posted ($0.38) earnings per share. The firm's revenue was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Research analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.